header advert
Results 1 - 2 of 2
Results per page:
Applied filters
General Orthopaedics

Include Proceedings
Dates
Year From

Year To
Orthopaedic Proceedings
Vol. 102-B, Issue SUPP_1 | Pages 96 - 96
1 Feb 2020
Harris A Christen B Malcorps J O'Grady C Sensiba P Vandenneucker H Huang B Cates H Hur J Marra D Kopjar B
Full Access

Introduction

Patients ≤ 55 years have a high primary TKA revision rate compared to patients >55 years. Guided motion knee devices are commonly used in younger patients yet outcomes remain unknown.

Materials and Methods

In this sub-group analysis of a large multicenter study, 254 TKAs with a second-generation guided motion knee implant (Journey II Bi-Cruciate Stabilized Knee System, Smith & Nephew, Inc., Memphis) were performed between 2011–2017 in 202 patients ≤ 55 years at seven US and three European sites. Revision rates were compared with Australian Joint Registry (AOANJRR) 2017 data.


Orthopaedic Proceedings
Vol. 102-B, Issue SUPP_1 | Pages 95 - 95
1 Feb 2020
Harris A Christen B Malcorps J O'Grady C Sensiba P Vandenneucker H Huang B Cates H Hur J Marra D Kopjar B
Full Access

Introduction/Aim

Outcomes for guided motion primary total knee arthroplasty (TKA) in obese patients are unknown.

Materials and Methods

1,684 consecutive patients underwent 2,059 primary TKAs with a second-generation guided motion implant (Journey II Bi-Cruciate Stabilized Knee System, Smith & Nephew, Inc., Memphis) between 2011–2017 at three European and seven US sites.